These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9548386)
1. The potency of the novel tachykinin receptor antagonist CGP49823 at rat and gerbil motoneurones in vitro. Pozza MF; Olpe HR; Ofner S; Schoeffel C; Evans RH Eur J Pharmacol; 1998 Jan; 342(2-3):203-8. PubMed ID: 9548386 [TBL] [Abstract][Full Text] [Related]
2. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord. Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986 [TBL] [Abstract][Full Text] [Related]
3. Tachykinin NK1 receptor subtypes in the rat urinary bladder. Meini S; Patacchini R; Maggi CA Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327 [TBL] [Abstract][Full Text] [Related]
4. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230 [TBL] [Abstract][Full Text] [Related]
5. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists. Rupniak NM; Tattersall FD; Williams AR; Rycroft W; Carlson EJ; Cascieri MA; Sadowski S; Ber E; Hale JJ; Mills SG; MacCoss M; Seward E; Huscroft I; Owen S; Swain CJ; Hill RG; Hargreaves RJ Eur J Pharmacol; 1997 May; 326(2-3):201-9. PubMed ID: 9196273 [TBL] [Abstract][Full Text] [Related]
7. Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord. Hosoki R; Yanagisawa M; Guo JZ; Yoshioka K; Maehara T; Otsuka M Br J Pharmacol; 1994 Dec; 113(4):1141-6. PubMed ID: 7534180 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal motoneurones. Yanagisawa M; Otsuka M Br J Pharmacol; 1990 Aug; 100(4):711-6. PubMed ID: 1698496 [TBL] [Abstract][Full Text] [Related]
9. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist. Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789 [TBL] [Abstract][Full Text] [Related]
11. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII. Broccardo M; Improta G; Tabacco A Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091 [TBL] [Abstract][Full Text] [Related]
12. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor. Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625 [TBL] [Abstract][Full Text] [Related]
13. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Torrens Y; Saffroy M; Glowinski J; Beaujouan JC Neuropeptides; 1997 Jun; 31(3):243-51. PubMed ID: 9243521 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556 [TBL] [Abstract][Full Text] [Related]
15. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum. Cheng FH; Chan SW; Rudd JA Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934 [TBL] [Abstract][Full Text] [Related]
16. Tachykinin NK1 receptors mediate both vasoconstrictor and vasodilator responses in the rabbit isolated jugular vein. Patacchini R; Maggi CA Eur J Pharmacol; 1995 Sep; 283(1-3):233-40. PubMed ID: 7498315 [TBL] [Abstract][Full Text] [Related]
17. Functional characterisation of tachykinin receptors mediating ion transport in porcine jejunum. Thorbøll JE; Bindslev N; Hansen MB; Schmidt P; Skadhauge E Eur J Pharmacol; 1998 Oct; 359(2-3):271-9. PubMed ID: 9832399 [TBL] [Abstract][Full Text] [Related]
18. Demonstration of a 'septide-sensitive' inflammatory response in rat skin. Ahluwalia A; Giuliani S; Maggi CA Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286 [TBL] [Abstract][Full Text] [Related]
20. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists. Duffy RA; Varty GB; Morgan CA; Lachowicz JE J Pharmacol Exp Ther; 2002 May; 301(2):536-42. PubMed ID: 11961054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]